Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 990 | 1033 | 1004 | 1239 | 1272 | 1621 |
Fund Return | -0.95% | 3.34% | 0.42% | 7.39% | 4.93% | 4.95% |
Place in category | 382 | 372 | 357 | 252 | 203 | 120 |
% in Category | 58 | 50 | 56 | 52 | 47 | 35 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
FC Responsible Global Equity Fund 2 | 1.29B | 9.14 | 6.49 | 12.49 | ||
FC Responsible Global Equity 1 Acc | 1.29B | 5.68 | 5.70 | 11.23 | ||
FC Responsible Global Equity 1 Inc | 1.29B | 5.64 | 5.43 | 11.09 | ||
FC Responsible Global Equity 2 Acc | 1.29B | 5.81 | 6.53 | 12.17 | ||
FC Responsible Global Equity 4 Inc | 1.29B | 5.95 | 7.30 | 12.94 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Index Unit Trust Accumulation | 13.9B | 4.02 | 7.99 | 5.79 | ||
All Share Index Unit Trust Income | 13.9B | -0.70 | 7.89 | - | ||
VG UK Plus GBP Accumulation | 13.9B | -0.70 | 7.91 | - | ||
VG UK Institutional Plus GBP Income | 13.9B | -0.69 | 7.90 | - | ||
UK Equity Tracker Fund D Acc | 11.62B | 2.82 | 7.88 | 5.79 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Shell | GB00BP6MXD84 | 6.99 | 33.87 | +1.18% | |
AstraZeneca | GB0009895292 | 6.38 | 12,050.0 | -0.87% | |
HSBC | GB0005405286 | 5.09 | 705.50 | +0.07% | |
Unilever | GB00B10RZP78 | 4.16 | 48.56 | -0.49% | |
BP | GB0007980591 | 3.31 | 510.40 | -1.05% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review